SkinHealth Systems (SKIN) Research & Development (2020 - 2026)

SkinHealth Systems (SKIN) has 7 years of Research & Development data on file, last reported at $23.2 million in Q1 2026.

• On a quarterly basis, Research & Development fell 10.93% year-over-year to $23.2 million in Q1 2026; TTM through Mar 2026 was $27.8 million, a 50.35% decrease from a year earlier, with the FY2025 full-year figure at $5.6 million, down 10.61% from the prior year.
• Research & Development for Q1 2026 stood at $23.2 million, up from $1.7 million in the prior quarter.
• Over the last five years, Research & Development for SKIN reached as high as $39.8 million in Q3 2022 and fell as low as $1.2 million in Q2 2024.
• Historically, Research & Development has averaged $12.2 million across 5 years, with a median of $2.6 million in 2022.
• Across the five-year window, Research & Development sank 95.38% in 2023 and jumped 1401.9% in 2024, its largest moves.
• Year by year, Research & Development stood at $1.4 million in 2022, then soared by 110.65% to $3.0 million in 2023, then slumped by 59.88% to $1.2 million in 2024, then soared by 37.56% to $1.7 million in 2025, then jumped by 1279.83% to $23.2 million in 2026.
• Per Business Quant data, the three most recent Research & Development figures were $23.2 million in Q1 2026, $1.7 million in Q4 2025, and $1.7 million in Q3 2025.